phase readout
saveNCT07758595: A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL921 in Healthy Participants and Participants With Alzheimer's Disease
NOT_YET_RECRUITINGupdated 48m ago
community read0 votes
Sponsor: Denali Therapeutics Inc.. Phase: PHASE1. Conditions: Alzheimer's Disease, Healthy Participants
view source ↗
comments(0)
5-min edit window · permanent after that